Vetter announces leadership transition as Thomas Otto retires
Esme Needham | December 5, 2025 | Appointment | | Managing Director, Vetter
Vetter has announced the retirement of managing director Thomas Otto amid strategic plans for restructuring its management team.
Otto has served at Vetter for over 35 years and has been heavily involved in shaping the company’s sustainable development and continued growth. He will step down at the end of 2025 and take on an advisory role, enabling him to contribute his experience of pharmaceutical construction projects to the planned development of a new production site in Germany.
“Thomas Otto has decisively advanced our family business with his vision, innovative strength and great sense of responsibility. His contribution to Vetter’s development and internationalisation is outstanding and deserves the highest recognition,” Udo J Vetter, chairman of the Advisory Board and member of the owner family, said.
Vetter is ensuring continuity within the company by instituting a strategic plan to restructure its management team. In early 2025, long-term Vetter executives Henryk Badack, Titus Ottinger and Carsten Press were appointed to the Management Board as managing directors. Their extensive knowledge of the company will allow them to assist in Vetter’s future development.
Founded in 1950, Vetter is a Contract Development and Manufacturing Organisation (CDMO) with production facilities in Germany, Austria and the US, as well as an independent pharmaceutical services presence in the Asia-Pacific market. Vetter is a global supplier of medicines, providing full-stage support from drug development to clinical and commercial filing and manufacturing.
Related Content
Vetter swells filling capacity with $100m investment
German contract development and manufacturing organisation (CDMO) Vetter says it is planning to invest over …
Pharma manufacturing news in brief
Excipients trade body IPEC will set up a branch in India next month, plus updates …
